Annual Long Term Debt
$20.03 M
+$636.50 K+3.28%
December 31, 2023
Summary
- As of February 25, 2025, PRQR annual long term debt is $20.03 million, with the most recent change of +$636.50 thousand (+3.28%) on December 31, 2023.
- During the last 3 years, PRQR annual long term debt has fallen by -$19.18 million (-48.92%).
- PRQR annual long term debt is now -67.28% below its all-time high of $61.22 million, reached on December 31, 2021.
Performance
PRQR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$12.85 M
-$1.17 M-8.37%
September 1, 2024
Summary
- As of February 25, 2025, PRQR quarterly long term debt is $12.85 million, with the most recent change of -$1.17 million (-8.37%) on September 1, 2024.
- Over the past year, PRQR quarterly long term debt has stayed the same.
- PRQR quarterly long term debt is now -79.02% below its all-time high of $61.22 million, reached on December 31, 2021.
Performance
PRQR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
PRQR Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3.3% | 0.0% |
3 y3 years | -48.9% | -31.1% |
5 y5 years | +86.6% | -31.1% |
PRQR Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -67.3% | +3.3% | -79.0% | at low |
5 y | 5-year | -67.3% | +40.7% | -79.0% | +133.1% |
alltime | all time | -67.3% | >+9999.0% | -79.0% | +838.7% |
ProQR Therapeutics NV Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $12.85 M(-8.4%) |
Jun 2024 | - | $14.02 M(-2.9%) |
Mar 2024 | - | $14.44 M(-27.9%) |
Dec 2023 | $20.03 M(+3.3%) | $20.03 M(+8.5%) |
Sep 2023 | - | $18.47 M(-1.6%) |
Jun 2023 | - | $18.77 M(-0.7%) |
Mar 2023 | - | $18.90 M(-2.5%) |
Dec 2022 | $19.39 M(-68.3%) | $19.39 M(+4.1%) |
Sep 2022 | - | $18.64 M(-65.9%) |
Jun 2022 | - | $54.67 M(-7.1%) |
Mar 2022 | - | $58.88 M(-3.8%) |
Dec 2021 | $61.22 M(+56.1%) | $61.22 M(+61.8%) |
Sep 2021 | - | $37.84 M(-2.0%) |
Jun 2021 | - | $38.60 M(+3.1%) |
Mar 2021 | - | $37.44 M(-4.5%) |
Dec 2020 | $39.21 M(+175.4%) | $39.21 M(+6.8%) |
Sep 2020 | - | $36.73 M(+566.6%) |
Jun 2020 | - | $5.51 M(-62.0%) |
Mar 2020 | - | $14.48 M(+1.7%) |
Dec 2019 | $14.24 M | $14.24 M(+23.8%) |
Sep 2019 | - | $11.50 M(-7.8%) |
Jun 2019 | - | $12.47 M(-0.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $12.48 M(+16.3%) |
Dec 2018 | $10.74 M(+69.4%) | $10.74 M(+46.1%) |
Sep 2018 | - | $7.35 M(+5.5%) |
Jun 2018 | - | $6.96 M(-1.4%) |
Mar 2018 | - | $7.06 M(+11.4%) |
Dec 2017 | $6.34 M(+5.3%) | $6.34 M(-17.0%) |
Sep 2017 | - | $7.64 M(+9.7%) |
Jun 2017 | - | $6.96 M(+11.5%) |
Mar 2017 | - | $6.24 M(+3.6%) |
Dec 2016 | $6.02 M(+14.2%) | $6.02 M(+48.1%) |
Sep 2016 | - | $4.07 M(-30.6%) |
Jun 2016 | - | $5.86 M(+0.5%) |
Mar 2016 | - | $5.83 M(+10.5%) |
Dec 2015 | $5.27 M(+53.3%) | $5.27 M(+8.2%) |
Sep 2015 | - | $4.88 M(+2.7%) |
Jun 2015 | - | $4.75 M(+51.6%) |
Mar 2015 | - | $3.13 M(-9.0%) |
Dec 2014 | $3.44 M(+151.4%) | $3.44 M(-2.9%) |
Sep 2014 | - | $3.54 M(-4.4%) |
Jun 2014 | - | $3.70 M(+170.7%) |
Dec 2013 | $1.37 M(+977.5%) | $1.37 M |
Dec 2012 | $127.00 K | - |
FAQ
- What is ProQR Therapeutics NV annual long term debt?
- What is the all time high annual long term debt for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual long term debt year-on-year change?
- What is ProQR Therapeutics NV quarterly long term debt?
- What is the all time high quarterly long term debt for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly long term debt year-on-year change?
What is ProQR Therapeutics NV annual long term debt?
The current annual long term debt of PRQR is $20.03 M
What is the all time high annual long term debt for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual long term debt is $61.22 M
What is ProQR Therapeutics NV annual long term debt year-on-year change?
Over the past year, PRQR annual long term debt has changed by +$636.50 K (+3.28%)
What is ProQR Therapeutics NV quarterly long term debt?
The current quarterly long term debt of PRQR is $12.85 M
What is the all time high quarterly long term debt for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly long term debt is $61.22 M
What is ProQR Therapeutics NV quarterly long term debt year-on-year change?
Over the past year, PRQR quarterly long term debt has changed by $0.00 (0.00%)